arrow
H

Hanne Lindegaard

University of Southern Denmark
H指数:35
被引数:5,054

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The multidisciplinary approach to eosinophilia
2023-05-1810
OAAI
Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis The IMAGINE-RA Randomized Clinical Trial
2019-02-0569
OAAI
AN MRI GUIDED TREAT-TO-TARGET STRATEGY IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION IMPROVED MRI INFLAMMATION BUT NOT DAMAGE PROGRESSION - RESULTS FROM THE IMAGINE-RA RANDOMISED CONTROLLED TRIAL
2018-06-010
OAAI
THE VALUE OF ADDING MRI TO A CLINICAL TREAT-TO-TARGET STRATEGY IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION: CLINICAL AND RADIOGRAPHIC OUTCOMES FROM THE IMAGINE-RA RANDOMISED CONTROLLED TRIAL
2018-06-012
OAAI
Galectin-3 is Persistently Increased in Early Rheumatoid Arthritis (RA) and Associates with Anti-CCP Seropositivity and MRI Bone Lesions, While Early Fibrosis Markers Correlate with Disease Activity
2017-11-0126
OAAI
CLINICAL OUTCOMES FROM A NATIONWIDE NON-MEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR ETANERCEPT IN PATIENTS WITH INFLAMMATORY ARTHRITIS AFTER 5 MONTHS FOLLOW-UP. RESULTS FROM THE DANBIO REGISTRY
2017-06-0116
OAAI
Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)

使用甲氨蝶呤和关节内糖皮质激素联合或不联合阿达木单抗诱导的靶向治疗策略的临床和影像学结果: 一项为期2年的研究者发起的双盲随机对照试验 (OPERA)

2016-09-0140
PREAI
CHANGES IN MULTI-BIOMARKER DISEASE ACTIVITY (MBDA) SCORE CORRELATE WITH CHANGES IN ESTABLISHED DISEASE ACTIVITY MEASUREMENTS IN PATIENTS WITH EARLY RA FROM THE OPERA STUDY
2016-06-010
PREAI
MAGNETIC RESONANCE IMAGING JOINT SPACE NARROWING IS AN INDEPENDENT PREDICTOR OF RADIOGRAPHIC AND MRI DAMAGE PROGRESSION IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
2016-06-010
PREAI
HAND BONE LOSS IN EARLY RHEUMATOID ARTHRITIS IS INDEPENDENT OF ADALIMUMAB TREATMENT. A SUBSTUDY OF THE OPTIMIZED TREATMENT ALGORITHM IN EARLY RA (OPERA) TRIAL
2016-06-010
PREAI